Head of Global Medical & Scientific Affairs
Glucose Monitoring and Science
Roche Diabetes Care GmbH
Dr. Rolf HINZMANN (MD, PhD), is ‘Head of Global Medical Affairs, Glucose Monitoring and Science’ at Roche Diabetes Care and is based in Mannheim, Germany. The focus of his work is on self-monitoring of blood glucose and continuous glucose monitoring and the role of technology, combined with digital solutions, for achieving sustainable behavioral change in patients with chronic disease.
Dr. Hinzmann studied Medicine and Biochemistry at Hannover Medical School and Hannover University, Germany, and completed his PhD in Biochemistry at the Max Planck Institute for Experimental Endocrinology in Hannover. Thereafter, he worked in the field of laboratory diagnostics (clinical chemistry, immunology, haematology, immunohaematology, blood banking, microbiology, serology, molecular biology) and internal medicine at Hannover Medical School and qualified as Clinical Pathologist (in German: Arzt für Laboratoriumsmedizin).
He continued his medical career in the in-vitro diagnostic industry where he spent over 20 years in various management positions at Beckman Coulter as a European Scientific Marketing Manager, at Sysmex Europe as Medical Director Europe, and since 2010 in the above-mentioned position at Roche.
Dr. Hinzmann has many publications in the field of clinical chemistry, haematology and diabetes and is a requested lecturer at scientific conferences. Several times he was rated distinguished speaker by the American Association of Clinical Chemistry (AACC).
His special interests are evidence-based medicine, cardiovascular disease, diabetes and metabolism, standardization of laboratory tests, point-of-care testing, self-empowerment of patients and behavioral change, didactics in medicine and philosophy of science.
Dr. Hinzmann held various positions in the IFCC: Corporate Representative of the Executive Committee of the Scientific Division (2001-2006), Corporate Representative of the Executive Committee of the Education & Management Division (2007-2012), and Member of the Task Force POCT (2013-2014).
Since 2015 Dr. Hinzmann has acted as the interface between IFCC and the in-vitro diagnostic industry as Corporate Representative at the IFCC Executive Board.